Tested Applications
| Positive WB detected in | HT-29 cells, mouse bone marrow tissue, SW480 cells |
| Positive IF-P detected in | mouse spleen tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 |
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
31721-1-AP targets Lipocalin-2/NGAL in WB, IHC, IF-P, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse, chicken |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Eg0998 Product name: Recombinant Human Lipocalin-2/NGAL protein (His Tag) Source: mammalian cells-derived, pHZ-KIsec-C-6*HIS Tag: C-10*His Domain: 21-198 aa of NM_005564.5 Sequence: QDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGCQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG Predict reactive species |
| Full Name | lipocalin 2 |
| Calculated Molecular Weight | 23kDa |
| Observed Molecular Weight | 22 kDa |
| GenBank Accession Number | NM_005564.5 |
| Gene Symbol | NGAL/LCN2 |
| Gene ID (NCBI) | 3934 |
| RRID | AB_3670098 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity Purification |
| UNIPROT ID | P80188-1 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Lipocalin-2 (LCN-2) is a adipocytokine also referred to as neutrophil gelatinase-associated lipocalin (NGAL). Lipocalin-2 is a circulatory protein responsible for the transportation of small and hydrophobic molecules to target organs. Lipocalin-2 is used as a biomarker for acute and chronic renal injury. It is present in a large variety of cells including neutrophil, hepatocytes, lung, bone marrow, adipose tissue, macrophages, thymus, non-neoplastic breast duct, prostate, and renal cells. Different functions have been associated with Lipocalin-2, including antibacterial, anti-inflammatory, and protection against cell and tissue stress (PMID:34463264).
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for Lipocalin-2/NGAL antibody 31721-1-AP | Download protocol |
| WB protocol for Lipocalin-2/NGAL antibody 31721-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Lipocalin-2/NGAL Polyclonal antibody (Cat# 31721-1-AP) has 13 citations published across 11 journals, including Pharmacological Research, Free Radical Biology and Medicine, International Immunopharmacology, FASEB Journal, Scientific Reports, Cell Molecular Gastroenterology and Hepatology, Renal Failure, Molecular Medicine Reports, Veterinary Research Communications, Archives of Immunology and Therapy Experimental, and bioRxiv. Research fields span kidney injury, oncology (NSCLC, cervical cancer), epilepsy, Crohn's disease, oxidative stress, inflammation, and ferroptosis.
| Species | Application | Title |
|---|---|---|
Pharmacol Res Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathway
| ||
Cell Mol Gastroenterol Hepatol An Epigenetic Basis for Sustained Inflammatory Epithelial Progenitor Cell States in Crohn's Disease. | ||
Free Radic Biol Med MICU1 deficiency exacerbates cisplatin-induced acute kidney injury by tubular apoptosis and mitochondrial dysfunction. | ||
Free Radic Biol Med Astrocytic LCN2 drives neuronal dysfunction in epilepsy by suppressing tunnel nanotube-mediated mitochondrial transfer via NLRP3 inflammasome activation.
| ||
Int Immunopharmacol The protective effect of Lcn2 activation on salivary gland injury in sialadenitis. | ||
Int Immunopharmacol N-acetylglucosamine ameliorates the transition from acute kidney injury to chronic kidney disease by reducing the accumulation of lipid droplets. |





